(Solved): Fizer Pharmaceutical paid $73 million on January 2,2024 , for 9 million shares of Carne Cosmetics c ...

Fizer Pharmaceutical paid $$\$73$$ million on January 2,2024 , for 9 million shares of Carne Cosmetics common stock. The investment represents a $$25\%$$ interest in the net assets of Carne and gave Fizer the ability to exercise significant influence over Carne's operations. Fizer received dividends of $$\$1$$ per share on December 21,2024 , and Carne reported net income of $$\$44\mathrm{million}$$ for the year ended December 31, 2024. The fair value of Came's common stock at December 31,2024 , was $$\$23.50$$ per share. - The book value of Carne's net assets was $$\$176$$ million. - The fair value of Came's depreciable assets exceeded their book value by $$\$48$$ million. These assets had an average remaining useful life of twelve years. - The remainder of the excess of the cost of the investment over the book value of net assets purchased was attributable to goodwill. Required: Complete the table below and prepare the appropriate journal entries related to the investment during 2024. Complete this question by entering your answers in the tabs below. Complete the table bejow. Note: Enter your answers in mallions, (i.e., 10,000,000 should be entered as 10$$)$$. Journal entry worksheet Record the fair value adjustment at year-end. Note: Enter debits before credits.